Markers of bone formation and resorption, such as alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OC), have demonstrated potential as genetic indicators of bone metastasis in prostate cancer. This evidence concerns the gene SPP1 and prostate cancer.